Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Progressive Pulmonary Fibrosis ...

The increase in the global burden of interstitial lung disease (ILD) and pulmonary sarcoidosis had the greatest impact on ...

Researchers investigate how short-term exposure to ambient air pollution and temperature affects bronchiectasis mortality ...

The ILD Summit is accredited by the American Association of Continuing Medical Education (ACCME) and the British Academy of ...

The Pulmonary Fibrosis Foundation (PFF) has launched “PF Basics: Info for Newly Diagnosed Patients,” a new educational program to help patients with pulmonary fibrosis (PF) and interstitial lung ...

Corporate presentation will be held on Wednesday, December 4, 2024, at 1:00 p.m. ET NEW HAVEN, Conn., Nov. 21, 2024 /PRNe ...

Since her IPF diagnosis in 2016, columnist Charlene Marshall has learned to manage her emotions — expect when a loved one gets the same news.

Researchers from Vanderbilt University have developed a system of artificial cilia that can reportedly monitor mucus ...

Sarepta Therapeutics is paying Arrowhead Pharmaceuticals $500 million in cash, plus a $325 million equity investment, for ...

26, 2024 — What factors lead to chronic respiratory disease ... hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying molecule is as ...

By Christopher Gannatti, CFAIn November 2024, it isn’t difficult to find all sorts of perspectives on the so-called ...

New opioid prescriptions for patients in the UK mostly written for musculoskeletal conditions, in which there is little evidence for opioid efficacy.